A federal district court in California has rejected the FDA’s attempt to enjoin a stem cell clinic from performing procedures involving what the agency alleged to be unapproved drugs and biological products. The court held that the clinic’s current procedures did not involve products that were subject to FDA regulation (United States v. California Stem Cell Treatment Center, N... Read More